Capricorn Partners seeks EUR 25m for industrial biotech VC fund
Belgian VC investor Capricorn Partners is open to more investor approaches for its new industrial biotech fund as it aims for a final close on EUR 25m by the end of next year, partner Rob van der Meij told Unquote.
More on Venture
Moonfire Ventures raises USD 115m to back early-stage startups in Europe
AI-powered VC firm has raised USD 90m for Fund II and USD 25m for its Opportunity Fund to double down on winners
Hamilton Lane targets global impact opportunities with new USD 370m fund
Asset manager’s new fund will make direct investments and can take larger stakes than its USD 95m predecessor
Bregal Milestone closes second tech fund on EUR 770m
European technology investor has around 60% dry powder remaining to deploy in its latest fund
Polestar Capital to raise up to EUR 500m for new e-mobility investment strategy
Dutch GP plans to close new vehicle in mid-2024 as Circular Debt fundraising continues
Latest News
Golding aims to raise EUR 350m for next buyout co-investment fund amid ‘unprecedented’ dealflow
Vehicle expects to make its first deals this year, providing additional equity for deals against a tough fundraising backdrop
Permira to acquire majority stake in Gruppo Florence
Existing shareholders including VAM Investments and management of the Italian fashion group will reinvest, while Italmobiliare will exit
Mimir Group ramps up global origination effort with London office and focus on life science carve-outs
Stockholm-based investor is considering divestments, although challenging market remains a barrier
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt